🖤 Donations of all sizes power our public service journalism Give Now

Latest Stories

Latest Stories

The payoff

Jan 10, 2006
This morning I realized I'm actually in China. I've been here for five days, but with the final preparation for our live broadcasts, I have barely...

Kai and the Ryss Dolls

Jan 10, 2006
The China team has been able to peel away a slice of time for fun too......

Hot Rats

Jan 10, 2006
There are astoundingly striking skyscrapers in Shanghai. Beautiful, shimmering architectural wonders – I marvel at how they're able to bend the...

"One Billion Customers"

Jan 9, 2006
Kai Ryssdal talks with former Wall Street Journal reporter James McGregor about his book "One Billion Customers." They discuss China's economic transition and how the country's explosive growth is affecting the world.

All in a day's work...

Jan 8, 2006
So the truth of the matter is I’m not sleeping very well. Seems like every morning I wake up at 3 or 3:15, toss and turn for a couple of hours,...

Am I being watched?

Jan 7, 2006
It's my first visit to China. And I wasn't quite sure what to expect. Would we have government minders buzzing around us at all times? Would the...

Jet-lag and deadlines

Jan 7, 2006
This is my third trip to China in four months, and if I've come to understand anything about this fascinating, enormous, staggering country, it's...

For public good, not for profit.

Unemployment in 2005

Jan 6, 2006
Business editor Cheryl Glaser takes a look at what the government's year-end unemployment stats are likely to say when they come out today, and what they could portend for 2006.

The Job Files: Pharmacist

Jan 6, 2006
In this installment of the Job Files, we check in with pharmacist Steve Kaufman.

Cloning scandal fallout

Jan 6, 2006
Repercussions from the South Korean cloning scandal continue to reverberate. This week, Science magazine announced a rare retraction of an article authored by the researcher at the heart of the scandal. Helen Palmer looks at whether the scandal has cooled investor enthusiasm for life sciences ventures.